Skip to main content
Top
Published in: European Journal of Medical Research 1/2020

Open Access 01-12-2020 | Acute Kidney Injury | Research

Shock wave lithotripsy, for the treatment of kidney stones, results in changes to routine blood tests and novel biomarkers: a prospective clinical pilot-study

Authors: Stephen F. Hughes, Nathan Jones, Samantha J. Thomas-Wright, Joseph Banwell, Alyson J. Moyes, Iqbal Shergill

Published in: European Journal of Medical Research | Issue 1/2020

Login to get access

Abstract

Background

The number of patients undergoing shock wave lithotripsy (SWL) for kidney stones is increasing annually, and as such the development of post-operative complications, such as haematuria and acute kidney injury (AKI) following SWL, is likely to increase. The aim of the study was to evaluate changes in routine blood and novel biomarkers following SWL, for the treatment of kidney stones.

Methods

Twelve patients undergoing SWL for solitary unilateral kidney stones were recruited. From patients (8 males and 4 females) aged between 31 and 72 years (median 43 years), venous blood samples were collected pre-operatively (baseline), at 30, 120 and 240 min post-operatively. Routine blood tests were performed using a Sysmex XE-5000, and Beckman Coulter AU5800 and AU680 analysers. NGAL, IL-18, IL-6, TNF-α, IL-10 and IL-8 concentrations were determined using commercially available ELISA kits.

Results

Significant (p ≤ 0.05) changes were observed in several blood parameters following SWL. NGAL concentration significantly increased, with values peaking at 30 min post-treatment (p = 0.033). Although IL-18 concentration increased, these changes were not significant (p = 0.116). IL-6 revealed a statistically significant rise from pre-operative up to 4 h post-operatively (p < 0.001), whilst TNF-α significantly increased, peaking at 30 min post-SWL (p = 0.05). There were no significant changes to IL-10 and IL-8 concentrations post-SWL (p > 0.05).

Conclusions

Changes to routine blood tests and specific biomarkers, in the future, may be more useful for clinicians. In turn, identification of a panel of biomarkers could provide valuable data on “normal” physiological response after lithotripsy. Ultimately, studies could be expanded to identify or predict those patients at increased risk of developing post-operative complications, such as acute kidney injury or. These studies, however, need validating involving larger cohorts.
Literature
1.
go back to reference Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–96.PubMedPubMedCentral Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–96.PubMedPubMedCentral
4.
go back to reference Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V. First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol. 1981;167(5):1957–60.CrossRef Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V. First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol. 1981;167(5):1957–60.CrossRef
8.
go back to reference Newman R, Hackett R, Senior D, Brock K, Feldman J, Sosnowski J, Finlayson B. Pathologic effects of ESWL on canine renal tissue. Urology. 1987;29(2):194–200.CrossRef Newman R, Hackett R, Senior D, Brock K, Feldman J, Sosnowski J, Finlayson B. Pathologic effects of ESWL on canine renal tissue. Urology. 1987;29(2):194–200.CrossRef
9.
go back to reference Cornu JN, Herrmann T, Traxer O, Matlaga B. Prevention and management following complications from endourology procedures. Eur Urol Focus. 2016;2:49–59.CrossRef Cornu JN, Herrmann T, Traxer O, Matlaga B. Prevention and management following complications from endourology procedures. Eur Urol Focus. 2016;2:49–59.CrossRef
10.
go back to reference Skolarikos A, Gross A, Krebs A, Unal D, Bercowsky E, Eltahawy E, et al. Outcomes of flexible ureterorenoscopy for solitary renal stones in the CROES URS global study. J Urol. 2015;194:37–143.CrossRef Skolarikos A, Gross A, Krebs A, Unal D, Bercowsky E, Eltahawy E, et al. Outcomes of flexible ureterorenoscopy for solitary renal stones in the CROES URS global study. J Urol. 2015;194:37–143.CrossRef
11.
go back to reference Hassan I, Zietlow SP. Acute pancreatitis after extracorporeal shock wave lithotripsy for a renal calculus. Urology. 2002;60:1111.CrossRef Hassan I, Zietlow SP. Acute pancreatitis after extracorporeal shock wave lithotripsy for a renal calculus. Urology. 2002;60:1111.CrossRef
12.
go back to reference Rashid P, Steele D, Hunt J. Splenic rupture after extracorporeal shock wave lithotripsy. J Urol. 1996;156:1756–7.CrossRef Rashid P, Steele D, Hunt J. Splenic rupture after extracorporeal shock wave lithotripsy. J Urol. 1996;156:1756–7.CrossRef
13.
go back to reference Mobley TB, Myers DA, Grine WB, et al. Low energy lithotripsy with the Lithostar: treatment results with 19,962 renal and ureteral calculi. J Urol. 1993;149:1419–24.CrossRef Mobley TB, Myers DA, Grine WB, et al. Low energy lithotripsy with the Lithostar: treatment results with 19,962 renal and ureteral calculi. J Urol. 1993;149:1419–24.CrossRef
14.
go back to reference Patel KL, Gross J. Extracorporeal shock wave lithotripsy induced abdominal aortic aneurysm rupture. J Am Geriatr Soc. 1991;39:318–9.CrossRef Patel KL, Gross J. Extracorporeal shock wave lithotripsy induced abdominal aortic aneurysm rupture. J Am Geriatr Soc. 1991;39:318–9.CrossRef
23.
go back to reference Chawla LS, Seneff MG, Nelson DR, Williams M, Levy H, Kimmel PL, Macias WL. Elevated plasma concentrations of IL-6 and elevated APACHE 2 score predict acute kidney injury in patients with severe sepsis. CJASN. 2007;2(1):22–30.CrossRef Chawla LS, Seneff MG, Nelson DR, Williams M, Levy H, Kimmel PL, Macias WL. Elevated plasma concentrations of IL-6 and elevated APACHE 2 score predict acute kidney injury in patients with severe sepsis. CJASN. 2007;2(1):22–30.CrossRef
24.
go back to reference Kowen O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41:1074–87.CrossRef Kowen O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis. 2003;41:1074–87.CrossRef
25.
go back to reference Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum. 2002;46(11):3083–95. https://doi.org/10.1002/art.10563.CrossRefPubMed Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum. 2002;46(11):3083–95. https://​doi.​org/​10.​1002/​art.​10563.CrossRefPubMed
27.
go back to reference Chandrasekharan UM, Siemionow M, Unsal M, Yang L, Poptic E, Bohn J, Ozer K, Zhou Z, Howe PH, Penn M, DiCorleto P. Tumour necrosis factor α receptor 2 is required for TNF-α-induced leukocyte-endothelial interaction in vivo. Blood. 2007;109(5):1938–44.CrossRef Chandrasekharan UM, Siemionow M, Unsal M, Yang L, Poptic E, Bohn J, Ozer K, Zhou Z, Howe PH, Penn M, DiCorleto P. Tumour necrosis factor α receptor 2 is required for TNF-α-induced leukocyte-endothelial interaction in vivo. Blood. 2007;109(5):1938–44.CrossRef
28.
go back to reference Lauterbach M, O’Donnell P, Asano K, Mayadas TN. Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes. JLB. 2008;83(6):1423–30.PubMed Lauterbach M, O’Donnell P, Asano K, Mayadas TN. Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes. JLB. 2008;83(6):1423–30.PubMed
29.
go back to reference Shahzad A, Knapp M, Lang I, Kohler G. Interleukin-8 (IL-8)—a universal biomarker? Int Arch Med. 2010;3:11.CrossRef Shahzad A, Knapp M, Lang I, Kohler G. Interleukin-8 (IL-8)—a universal biomarker? Int Arch Med. 2010;3:11.CrossRef
30.
go back to reference Duan ZG, Yang WM. Analysis of cytokines (IL-2, IL-8, IL-10) in the expressed prostatic secretions of chronic prostatitis. Zhanghua Non Ke Xug. 2005;11(3):201–3. Duan ZG, Yang WM. Analysis of cytokines (IL-2, IL-8, IL-10) in the expressed prostatic secretions of chronic prostatitis. Zhanghua Non Ke Xug. 2005;11(3):201–3.
31.
go back to reference Rao WH, Evans GS, Finn A. The significance of interleukin 8 in urine. Arch Dis Child. 2001;85:256–62.CrossRef Rao WH, Evans GS, Finn A. The significance of interleukin 8 in urine. Arch Dis Child. 2001;85:256–62.CrossRef
32.
go back to reference Rabinovich A, Medina L, Piura B, Huleihel M. Expression of IL-10 in human normal and cancerous ovarian tissue cells. Eur Cytokine Netw. 2010;21(2):122–8.PubMed Rabinovich A, Medina L, Piura B, Huleihel M. Expression of IL-10 in human normal and cancerous ovarian tissue cells. Eur Cytokine Netw. 2010;21(2):122–8.PubMed
33.
go back to reference Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.CrossRef Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.CrossRef
36.
go back to reference Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T-cells. Nat Immunol. 2007;8:1372–9.CrossRef Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T-cells. Nat Immunol. 2007;8:1372–9.CrossRef
Metadata
Title
Shock wave lithotripsy, for the treatment of kidney stones, results in changes to routine blood tests and novel biomarkers: a prospective clinical pilot-study
Authors
Stephen F. Hughes
Nathan Jones
Samantha J. Thomas-Wright
Joseph Banwell
Alyson J. Moyes
Iqbal Shergill
Publication date
01-12-2020
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2020
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-020-00417-2

Other articles of this Issue 1/2020

European Journal of Medical Research 1/2020 Go to the issue